D-0760-2026 Class II Ongoing

Recalled by Shoolin Pharma Chem LLP — Kadi

FDA drug recall D-0760-2026 was initiated by Shoolin Pharma Chem LLP on Aug 3, 2026 and is designated Class II. Reason for recall: CGMP Deviations:Noted during FDA inspection The recall status is ongoing. Affected quantity: 1KG - 100-0.1KG(100gm) bags.

Recall details

Product Type
Drugs
Report Date
Aug 19, 2026
Initiation Date
Aug 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1KG - 100-0.1KG(100gm) bags

Product description

TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 1715996-29-5), NDC 85702-002-02.

Reason for recall

CGMP Deviations:Noted during FDA inspection

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot: TLF2506001, Date of Expiry: May 31, 2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0760-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0760-2026. Report a data issue: hello@regdatalab.com.